ADVFN US – Market Content Editor
-

Peloton stock rebounds after report suggests slow initial uptake of new AI-driven equipment
Peloton Interactive (NASDAQ:PTON) shares dipped about 0.5% early Tuesday but quickly rebounded after a Bloomberg report indicated that the company’s latest AI-enabled fitness products are off to a soft start. Bloomberg stated that Peloton’s new Cross Training Series has seen only limited early traction at major U.S. retail partners in the eight weeks since launch.…
-

Silexion stock jumps after toxicology studies show no systemic toxicity
Silexion Therapeutics Corp. (NASDAQ:SLXN) shares climbed 5.9% on Tuesday after the company reported encouraging results from toxicology studies for its pancreatic cancer candidate SIL204, confirming the absence of systemic organ toxicity in two animal models. The outcome marks a key milestone for the clinical-stage biotech firm, which remains on schedule to launch a Phase 2/3…
-

PharmaCyte Biotech stock surges following profitable exit from Femasys investment
PharmaCyte Biotech Inc. (NASDAQ:PMCB) shares skyrocketed 67.8% on Tuesday after the company announced it had completed the successful monetization of its stake in Femasys Inc. (NASDAQ:FEMY), significantly bolstering its liquidity. The sale is projected to lift PharmaCyte’s combined cash and marketable securities to roughly $20 million, up from $13.3 million reported as of July 31,…
-

Clean Energy Technologies stock soars after securing $10M BESS project
Clean Energy Technologies, Inc. (NASDAQ:CETY) shares surged 58.9% on Tuesday after the company announced it has won a $10 million contract to deliver a Battery Energy Storage System (BESS) project in New York State. The clean-tech firm said this award represents its largest energy-storage engagement to date, and marks the first of several similar installations…
-

Lixte Biotechnology shares slide following purchase of UK-based Liora
Lixte Biotechnology Holdings Inc. (NASDAQ:LIXT) saw its stock drop 11.5% on Tuesday after the company announced the completion of its acquisition of Liora Technologies Europe Ltd., a UK firm focused on developing electronically controlled proton therapy systems for oncology. As part of the deal, Lixte now owns Liora’s flagship LiGHT System (Linac for Image Guided…
-

Veralto shares advance following $435 million deal for In-Situ
Veralto Corp (NYSE:VLTO) climbed 3.3% in early Tuesday trading after the company unveiled a $435 million agreement to acquire In-Situ, a move that will broaden its footprint in the environmental water and hydrology technology sectors. The transaction—expected to close in the first quarter of 2026—will fold In-Situ’s specialized water analytics and monitoring tools into Veralto’s…
-

UniFirst stock rises after Engine Capital pushes board to consider potential sale
UniFirst Corporation (NYSE:UNF) saw its shares climb 3.6% on Monday after activist investor Engine Capital publicly called on the company’s board to evaluate a possible sale. In a letter addressed to UniFirst’s trustees, Engine Capital — which holds roughly 3.2% of UniFirst’s outstanding common stock — criticized the board for declining to engage in private…
-

AMD stock plunges 9% as Meta considers Google’s AI chips
AMD (NASDAQ:AMD) shares sank 9% by late morning on Tuesday, while Nvidia (NASDAQ:NVDA) slid 6.5%, after reports emerged that Meta Platforms (NASDAQ:META) may shift part of its future AI hardware spending toward Google’s custom processors — a move that could meaningfully disrupt the current GPU landscape. The Information reported that Google (NASDAQ:GOOGL) has begun actively…
-

Abercrombie & Fitch shares surge as earnings top estimates
Abercrombie & Fitch Co. (NYSE: ANF) jumped more than 16% in premarket trading after the retailer delivered stronger-than-expected third-quarter results and boosted its full-year guidance, helped by exceptional momentum at its Hollister brand. For the quarter, the company posted adjusted earnings of $2.36 per share, exceeding analyst expectations of $2.20. Revenue reached an all-time quarterly…
-

Best Buy shares climb after Q3 beat and upgraded full-year outlook
Best Buy (NYSE:BBY) traded more than 3% higher in Tuesday’s premarket session after the electronics retailer delivered stronger-than-anticipated fiscal third-quarter results for FY26 and raised its guidance for the year. The company posted earnings per share of $1.40, topping Wall Street’s $1.30 consensus estimate.Revenue also exceeded expectations, coming in at $9.67 billion versus the projected…